RT-qPCR was applied to assess PIK3C2A and TXNIP expressions in the studied groups, and the results revealed an upregulation of TXNIP and downregulation of PIK3C2A in patients with CAD as compared to the control group (Group I) (p < 0.001; Table 2). This evidence concerns the gene TXNIP and coronary artery disorder.